Status:
COMPLETED
Prediction of Hepatic Fibrosis in Patients With Chronic Hepatitis C by Biochemical and Duplex Doppler Indices
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Chronic Hepatitis C
Hepatic Fibrosis
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of our prospective study was to evaluate the value of Doppler parameters and compare the diagnostic accuracy of Doppler parameters with various biochemical indices in predicting significan...
Detailed Description
Chronic hepatitis C virus (HCV) infection is a global health problem, affecting about 3% of the world's population. Compared to patients with mild hepatic fibrosis, those with significant fibrosis are...
Eligibility Criteria
Inclusion
- Age older than 18 years
- Positive anti-HCV and HCV RNA for more than 6 months
- Alanine aminotransferase level more than twice the upper limit of normal (ULN)
Exclusion
- HBV and HCV co-infection
- HIV and HCV co-infection
- Heavy alcohol use (\> 50 gram/day)
- Autoimmune liver diseases
- Metabolic liver diseases
- Presence of hepatocellular carcinoma
Key Trial Info
Start Date :
January 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2007
Estimated Enrollment :
503 Patients enrolled
Trial Details
Trial ID
NCT00466336
Start Date
January 1 2003
End Date
January 1 2007
Last Update
March 6 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 100